These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1059704)

  • 1. A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
    Jennings R; Potter CW; McLaren C; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):341-52. PubMed ID: 1059704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.
    Potter CW; Jennings R; McLaren C; Edey D; Stuart-Harris CH; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):353-62. PubMed ID: 1059705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Virology; 1976 Feb; 69(2):511-22. PubMed ID: 1258359
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the antigenicity of influenza virus aluminum oxide adjuvant vaccine "Alorbat" in man (author's transl)].
    Desselberger U; Pressler K; Erdmann G
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):160-77. PubMed ID: 1179878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a zwitterionic detergent for the preparation of an influenza virus vaccine: 2. Immunogenicity of Empigen-treated virus in animals.
    Mukhlis FA; Crawford CR; Jennings R; Potter CW
    Vaccine; 1984 Sep; 2(3):199-203. PubMed ID: 6531962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):173-80. PubMed ID: 1068196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children.
    Eastwood LM; Jennings R; Milner RD; Potter CW
    J Clin Pathol; 1979 Jun; 32(6):534-7. PubMed ID: 469010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers.
    Brady MI; Furminger IG; Stones PB
    Postgrad Med J; 1976 Jun; 52(608):368-72. PubMed ID: 785427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibody to envelope antigens of Heq2Neq2 virus in ponies after infection and vaccination.
    Cameron TP; Kasel JA; Couch RB
    Proc Soc Exp Biol Med; 1974 Jul; 146(3):658-60. PubMed ID: 4858237
    [No Abstract]   [Full Text] [Related]  

  • 17. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):161-72. PubMed ID: 1068195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection.
    Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE
    J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.